Pharvaris N.V. (PHVS) vs Recursion Pharmaceuticals, Inc. (RXRX)
- Pharvaris N.V. PHVS 34.90 +7.29%
- Recursion Pharmaceuticals, Inc. RXRX 3.59 +2.57%
Pharvaris N.V. and Recursion Pharmaceuticals, Inc. are both Biotechnology companies. Pharvaris N.V. and Recursion Pharmaceuticals, Inc. are of similar size ($2.3B and $2.2B). Pharvaris N.V. has the higher net margin (0.00% vs −697.1%) and the higher return on invested capital (0.00% vs −88.5%). Across the 14 metrics below, Pharvaris N.V. leads on 7 and Recursion Pharmaceuticals, Inc. on 7.
Valuation
Profitability
| Metric | PHVS | RXRX | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 29.21% | 65.16% |
| Operating margin | 0.00% | (725.44%) | 0.00% |
| Net margin | 0.00% | (697.13%) | 0.00% |
| Free cash flow margin | 0.00% | (460.89%) | 0.00% |
| Return on equity | (71.50%) | (48.72%) | (50.12%) |
| Return on assets | (64.43%) | (36.29%) | (45.60%) |
| Return on invested capital | 0.00% | (88.54%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack